SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-22-006709
Filing Date
2022-04-29
Accepted
2022-04-29 16:06:44
Documents
17
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A oncr-20211231.htm   iXBRL 10-K/A 1258009
2 EX-10.13 oncr-ex10_13.htm EX-10.13 372669
3 EX-10.14 oncr-ex10_14.htm EX-10.14 134326
4 EX-31.1 oncr-ex31_1.htm EX-31.1 12707
5 EX-31.2 oncr-ex31_2.htm EX-31.2 12577
6 GRAPHIC img130720035_0.jpg GRAPHIC 20973
  Complete submission text file 0000950170-22-006709.txt   2163232

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncr-20211231_pre.xml EX-101.PRE 18543
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncr-20211231_lab.xml EX-101.LAB 30213
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncr-20211231.xsd EX-101.SCH 2620
11 EXTRACTED XBRL INSTANCE DOCUMENT oncr-20211231_htm.xml XML 11280
Mailing Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET SUITE 401 CAMBRIDGE MA 02139 857-320-6400
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39575 | Film No.: 22875231
SIC: 2834 Pharmaceutical Preparations